Vascular regulation of fatty acid transport in metastatic tumor outgrowth
Vascular regulation of fatty acid transport in metastatic tumor outgrowth
批准号:
10656015
负责人:
Jin Chen
金额:
$50.57万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2028-07-31
关键词:
AffectAmino AcidsAntibodiesAntigensAutomobile DrivingBODIPYBackBindingBiomassBlood VesselsCD36 geneCell ProliferationCellsClinicCollaborationsConfocal MicroscopyDataDetectionDevelopmentDistantDoseEndothelial CellsEndotheliumFABP3 geneFatty AcidsFluorescenceFunctional disorderFutureGlucoseGlutamineHumanImmuneImmunotherapyIn SituInhibition of Cell ProliferationKDR geneKnock-outLipidsLocationLoxP-flanked alleleLungMediatingMembrane ProteinsMetabolicMetabolismModelingMusNeoplasm MetastasisNeoplasms in Vascular TissueNutrientNutritional RequirementsOrganPalmitatesPatient-derived xenograft models of breast cancerPlayPolyunsaturated Fatty AcidsPopulationProductionRegulationRoleSignal TransductionSignaling MoleculeSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStreamSystemT cell therapyT-LymphocyteTechniquesTechnologyTestingTotal Internal Reflection FluorescentTrans Fatty AcidsTransportationVascular Endothelial CellVascular Endothelial Growth Factor Receptor-1Vascular EndotheliumVascular SystemWorkcancer cellcancer therapychemotherapyfatty acid metabolismfatty acid transportfatty acid-transport proteinimprovedin vivoinnovationlong chain fatty acidmass spectrometric imagingmetabolomicsmouse modelneoplastic cellneutralizing antibodypatient derived xenograft modeltranscriptome sequencingtumortumor microenvironmentuptake
中文摘要
项目概要
肿瘤转移需要支持性微环境以促进播散性肿瘤的生长
细胞。转移细胞从休眠状态转变为增殖状态需要营养物质
能源学和生物质生产。尽管肿瘤转移的代谢调控尚不完善
最近的研究证实了脂肪酸 (FA) 摄取和代谢的重要性
在驱动转移性肿瘤生长的肿瘤细胞中。然而,目前尚不清楚 FA 是如何在
肿瘤微环境受到调节。血管系统在供应血液中起着至关重要的作用
营养素。该应用研究血管内皮细胞如何调节 FA 运输
及其在转移性肿瘤生长中的利用。我们发现 Raptor/mTORC1 丢失,但是
血管内皮中的 Rictor/mTORC2 不抑制肺部转移性肿瘤的生长。
Raptor/mTORC1 缺陷导致长链脂肪酸 (LCFA) 和多不饱和脂肪减少
内皮细胞(EC)中的多不饱和脂肪酸(PUFA),介导的膜蛋白表达减少
FA 运输,减少 FA 摄取和跨内皮运输,并减少脂滴
在转移性肿瘤中。基于这些初步数据,我们提出了一个模型,其中 mTORC1
血管内皮细胞的活性刺激跨内皮 FA 转运,从而增强
FA 在肿瘤细胞和转移性生长中的利用。为了检验这个假设,我们将调查
血管 mTORC1 调节脂肪酸转运的下游机制
内皮细胞(目标 1)、刺激 FA 运输的上游因子(目标 2)以及
确定选择性阻断内皮 mTORC1 是否会抑制转移性生长,以及
改善针对转移的化疗和免疫疗法(目标 3)。拟议的工作具有创新性
mTORC1 的概念是调节脂肪酸的肿瘤血管运输。它还
采用多种最先进的技术,包括代谢组学筛选、MALDI 成像
用于肿瘤切片原位脂质/FA 检测的质谱法、乳腺癌 PDX 模型、
以及几种新的条件小鼠模型。这些研究将为未来奠定基础
开发选择性靶向内皮 mTORC1 或脂肪酸运输的策略
以改善抗癌治疗。
英文摘要
Project Summary
Tumor metastasis requires supportive microenvironment for outgrowth of disseminated tumor
cells. The switch of metastatic cells from dormant to proliferative state needs nutrients for
energetics and biomass production. Although metabolic regulation of tumor metastasis is not well-
established, recent studies demonstrated the importance of fatty acid (FA) uptake and metabolism
in tumor cells that drives metastatic tumor outgrowth. However, it is unclear how FA pools in the
tumor microenvironment is regulated. The vascular system plays a crucial role in supplying
nutrients. This application investigates how vascular endothelial cells regulate FA transportation
and utilization in metastatic tumor outgrowth. We discovered that loss of Raptor/mTORC1, but
not Rictor/mTORC2, in vascular endothelium inhibits metastatic tumor outgrowth in lung.
Raptor/mTORC1 deficiency led to reduced long chain fatty acid (LCFA) and polyunsaturated fatty
acid (PUFA) in endothelial cells (EC), decreased expression of membrane proteins that mediate
FA transport, reduced FA uptake and transport across endothelium, and decreased lipid droplets
in metastatic tumors. Based on these preliminary data, we propose a model in which mTORC1
activities in vascular endothelial cells stimulate transendothelial FA transport, leading to enhanced
FA utilization in tumor cells and metastatic outgrowth. To test this hypothesis, we will investigate
downstream mechanisms by which vascular mTORC1 regulates transport of fatty acids across
the endothelium (Aim 1), upper-stream factors that stimulate the FA transport (Aim 2), and
determine if selectively blocking endothelial mTORC1 will suppress metastatic outgrowth and
improve chemo- and immunotherapy against metastasis (Aim 3). The proposed work is innovative
in its concept that mTORC1 regulates tumor blood vessel transportation of fatty acids. It also
utilizes several state-of-the-art technologies, including a metabolomics screen, MALDI-imaging
mass spectrometry for lipid/FA detection on tumor section in situ, a breast cancer PDX model,
and several new conditional mouse models. These studies would set the stage for future
development of strategies selectively targeting endothelial mTORC1 or fatty acid transportation
to improve anti-cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10337024
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jin Chen
-
依托单位:
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10091653
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jin Chen
-
依托单位:
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10514613
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jin Chen
-
依托单位:
Defining the regulatory roles of alternative ribosome initiation and novel peptides
-
批准号:10311557
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2019
-
负责人:Jin Chen
-
依托单位:
Defining the regulatory roles of alternative ribosome initiation and novel peptides
-
批准号:10299750
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2019
-
负责人:Jin Chen
-
依托单位:
Defining the regulatory roles of alternative ribosome initiation and novel peptides
-
批准号:10013272
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2019
-
负责人:Jin Chen
-
依托单位:
Defining the regulatory roles of alternative ribosome initiation and novel peptides
-
批准号:9805566
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2019
-
负责人:Jin Chen
-
依托单位:
VEC3-Valve Enabled Cell Co-Culture Platforms for Cancer Biology Study
-
批准号:8153605
-
项目类别:
-
资助金额:$16.16万
-
财政年份:2011
-
负责人:Jin Chen
-
依托单位:
VEC3-Valve Enabled Cell Co-Culture Platforms for Cancer Biology Study
-
批准号:8331496
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2011
-
负责人:Jin Chen
-
依托单位:
Targeting EphA2 in lung cancer subtypes that are refractory to current therapy
-
批准号:8627397
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors
-
批准号:8195840
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors
-
批准号:7796394
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Role of mLST8 in mTORC2-dependent lung cancer that are refractory to targeted therapies
-
批准号:9898213
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors
-
批准号:8394586
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Targeting mTORC2 in lung squamous cancer
-
批准号:10583325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Role of mLST8 in mTORC2-dependent lung cancer that are refractory to targeted therapies
-
批准号:10265414
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors
-
批准号:7912971
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Jin Chen
-
依托单位:
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell
-
批准号:6912981
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2005
-
负责人:Jin Chen
-
依托单位:
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell
-
批准号:7050213
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2005
-
负责人:Jin Chen
-
依托单位:
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell
-
批准号:7204122
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2005
-
负责人:Jin Chen
-
依托单位:
海外基金